Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Annals of the Rheumatic Diseases|May 10, 2025
Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosusDionysis Nikolopoulos, George Sentis, Iasonas Kitsios, et al.
Annals of the Rheumatic Diseases|July 29, 2022
Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritisEleni Frangou, Panagiotis Garantziotis, Maria Grigoriou, et al.
Annals of the Rheumatic Diseases|June 24, 2021
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patientsKaterina Chavatza, Myrto Kostopoulou, Dionysis Nikolopoulos, et al.
Annals of the Rheumatic Diseases|November 7, 2024
Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathwaysGeorgia-Savina Moysidou, Panagiotis Garantziotis, George Sentis, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathwaysGeorgia-Savina Moysidou, Panagiotis Garantziotis, George Sentis, et al.
Signal Transduction and Targeted Therapy|June 10, 2026
Targeting NFATc1-regulated MTHFD2 one-carbon metabolism to suppress sustained T-cell-mediated inflammation in rheumatoid arthritisTheodora Manolakou, Jianyu Shen, Sanjaykumar Boddul, et al.
Annals of the Rheumatic Diseases|July 3, 2026
A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosusDionysis Nikolopoulos, Sofia Pitsigavdaki, Danae-Mona Nöthling, et al.
Annals of the Rheumatic Diseases|July 23, 2025
Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosusPanagiotis Garantziotis, Lorenzo Beretta, Julius Lindblom, et al.
Journal of Immunological Methods|July 3, 2024
Belimumab concentration measurements using a homologous anti-idiotype immunoassayFloris C Loeff, Ioannis Parodis, Tomas Walhelm, et al.
Seminars in Arthritis and Rheumatism|April 2, 2020
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational studySule Yavuz, Dondu U Cansu, Dionysis Nikolopoulos, et al.
Pageof 6